Variant report
Variant | rs4795367 |
---|---|
Chromosome Location | chr17:37608843-37608844 |
allele | C/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:5)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:5 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | POLR2A | chr17:37608144-37608912 | SK-N-MC | brain: | n/a | n/a |
2 | POLR2A | chr17:37606823-37609040 | MCF10A-Er-Src | breast: | n/a | n/a |
3 | FOXA2 | chr17:37608578-37608843 | HepG2 | liver: | n/a | n/a |
4 | POLR2A | chr17:37608109-37608900 | HepG2 | liver: | n/a | n/a |
5 | POLR2A | chr17:37606768-37608899 | HepG2 | liver: | n/a | n/a |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:37557413..37559525-chr17:37605171..37609188,5 | K562 | blood: | |
2 | chr17:37604386..37611889-chr17:37616048..37620931,25 | K562 | blood: | |
3 | chr17:37605291..37610010-chr17:37614517..37620203,14 | MCF-7 | breast: | |
4 | chr17:37604313..37610125-chr17:37615155..37621784,15 | MCF-7 | breast: | |
5 | chr17:37604291..37611614-chr17:37614953..37621274,26 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
MED1 | TF binding region |
ENSG00000266469 | Chromatin interaction |
ENSG00000167258 | Chromatin interaction |
ENSG00000108306 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs10445306 | 0.83[ASN][1000 genomes] |
rs10445307 | 0.80[ASN][1000 genomes] |
rs10491128 | 0.80[ASN][1000 genomes] |
rs1054488 | 0.83[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs11078899 | 0.96[AFR][1000 genomes];0.92[AMR][1000 genomes];0.90[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs11078900 | 0.86[ASN][1000 genomes] |
rs11078901 | 0.82[ASN][1000 genomes] |
rs11078902 | 0.85[ASN][1000 genomes] |
rs11078903 | 0.85[ASN][1000 genomes] |
rs11078904 | 0.83[ASN][1000 genomes] |
rs11657058 | 0.84[ASN][1000 genomes] |
rs11657153 | 0.84[ASN][1000 genomes] |
rs11657899 | 0.84[ASN][1000 genomes] |
rs11867312 | 0.86[ASN][1000 genomes] |
rs11868029 | 0.84[ASN][1000 genomes] |
rs11868030 | 0.84[ASN][1000 genomes] |
rs11870631 | 0.85[ASN][1000 genomes] |
rs11871813 | 0.83[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs12150047 | 0.98[AFR][1000 genomes];0.98[AMR][1000 genomes];0.95[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs12150493 | 0.83[ASN][1000 genomes] |
rs12449852 | 0.89[AFR][1000 genomes];0.87[AMR][1000 genomes];0.96[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs12452509 | 0.83[ASN][1000 genomes] |
rs12452682 | 0.85[ASN][1000 genomes] |
rs12452880 | 0.85[ASN][1000 genomes] |
rs12600751 | 0.80[ASN][1000 genomes] |
rs12936646 | 0.85[ASN][1000 genomes] |
rs12937013 | 0.85[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs12937703 | 0.81[ASN][1000 genomes] |
rs12938099 | 0.98[AFR][1000 genomes];0.94[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs12938268 | 0.83[ASN][1000 genomes] |
rs12941418 | 0.85[AFR][1000 genomes];0.83[AMR][1000 genomes];0.97[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs12942352 | 0.83[ASN][1000 genomes] |
rs12942360 | 0.82[ASN][1000 genomes] |
rs12942391 | 0.83[ASN][1000 genomes] |
rs12943928 | 0.85[ASN][1000 genomes] |
rs12947281 | 0.82[ASN][1000 genomes] |
rs12947506 | 0.83[ASN][1000 genomes] |
rs12947620 | 0.86[ASN][1000 genomes] |
rs12948906 | 0.85[ASN][1000 genomes] |
rs12950666 | 0.86[ASN][1000 genomes] |
rs1874226 | 0.83[ASN][1000 genomes] |
rs1971663 | 0.83[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs2338797 | 0.80[ASN][1000 genomes] |
rs2338799 | 0.83[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs28482878 | 0.83[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs28799952 | 0.85[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs34363096 | 0.86[ASN][1000 genomes] |
rs34432983 | 0.80[ASN][1000 genomes] |
rs35112839 | 0.86[ASN][1000 genomes] |
rs35285898 | 0.80[ASN][1000 genomes] |
rs35497503 | 0.86[ASN][1000 genomes] |
rs36064019 | 0.81[ASN][1000 genomes] |
rs4286140 | 0.86[ASN][1000 genomes] |
rs4287601 | 0.83[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs4332770 | 0.83[ASN][1000 genomes] |
rs4390625 | 0.86[ASN][1000 genomes] |
rs439537 | 0.83[ASN][1000 genomes] |
rs4410117 | 0.83[ASN][1000 genomes] |
rs4462633 | 0.85[ASN][1000 genomes] |
rs4488484 | 0.83[ASN][1000 genomes] |
rs4591174 | 0.86[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs4794808 | 0.85[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs4794810 | 0.86[ASN][1000 genomes] |
rs4795357 | 0.81[ASN][1000 genomes] |
rs4795358 | 0.87[AMR][1000 genomes];0.90[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs4795359 | 0.83[ASN][1000 genomes] |
rs4795364 | 0.82[ASN][1000 genomes] |
rs4795369 | 0.84[ASN][1000 genomes] |
rs4795371 | 0.83[ASN][1000 genomes] |
rs4795375 | 0.85[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs4795379 | 0.85[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs4795385 | 0.83[ASN][1000 genomes] |
rs55722796 | 0.84[ASN][1000 genomes] |
rs57399933 | 0.82[ASN][1000 genomes] |
rs57448077 | 0.85[ASN][1000 genomes] |
rs584377 | 0.81[ASN][1000 genomes] |
rs61161659 | 0.85[ASN][1000 genomes] |
rs62075056 | 0.80[ASN][1000 genomes] |
rs6503500 | 0.83[ASN][1000 genomes] |
rs6503504 | 0.83[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs6503513 | 0.81[ASN][1000 genomes] |
rs6503515 | 0.86[ASN][1000 genomes] |
rs6503517 | 0.83[ASN][1000 genomes] |
rs6503521 | 0.83[ASN][1000 genomes] |
rs665413 | 0.81[ASN][1000 genomes] |
rs667193 | 0.81[ASN][1000 genomes] |
rs7208252 | 0.84[AMR][1000 genomes];0.92[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs7208487 | 0.83[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs7212621 | 0.85[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs7215983 | 0.85[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs7218944 | 0.82[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs7219014 | 0.84[ASN][1000 genomes] |
rs7221117 | 0.84[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs7405667 | 0.83[ASN][1000 genomes] |
rs7501488 | 0.83[ASN][1000 genomes] |
rs7503081 | 0.83[ASN][1000 genomes] |
rs7503377 | 0.83[ASN][1000 genomes] |
rs801417 | 0.80[ASN][1000 genomes] |
rs8067511 | 0.94[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs8069074 | 0.84[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs8071300 | 0.83[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs8072351 | 0.83[ASN][1000 genomes] |
rs8073511 | 0.90[ASN][1000 genomes] |
rs8074276 | 0.89[AFR][1000 genomes];0.87[AMR][1000 genomes];0.99[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs8074855 | 0.95[AFR][1000 genomes];0.82[AMR][1000 genomes];0.96[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs8075737 | 0.83[ASN][1000 genomes] |
rs8076546 | 0.80[ASN][1000 genomes] |
rs8078599 | 0.83[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs8081528 | 0.85[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs8081780 | 0.84[ASN][1000 genomes] |
rs8182252 | 0.83[ASN][1000 genomes] |
rs903507 | 0.83[ASN][1000 genomes] |
rs9646419 | 0.96[AFR][1000 genomes];1.00[AMR][1000 genomes];0.96[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs9747983 | 0.84[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs9891892 | 0.86[ASN][1000 genomes] |
rs9892675 | 0.80[ASN][1000 genomes] |
rs9899069 | 0.83[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs9901219 | 0.81[ASN][1000 genomes] |
rs9904919 | 0.81[ASN][1000 genomes] |
rs9905432 | 0.80[ASN][1000 genomes] |
rs9906612 | 0.83[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs9908131 | 0.85[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs9909304 | 0.81[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs9912212 | 0.83[ASN][1000 genomes] |
rs9912310 | 0.83[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs9944459 | 0.83[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv932024 | chr17:37192290-37850932 | Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer Strong transcription Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 92 gene(s) | inside rSNPs | diseases |
2 | nsv1060126 | chr17:37333956-37659189 | Weak transcription ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Strong transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 55 gene(s) | inside rSNPs | diseases |
3 | nsv1057655 | chr17:37333956-37732451 | Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS Strong transcription Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 72 gene(s) | inside rSNPs | diseases |
4 | nsv1066033 | chr17:37333956-37795617 | Active TSS Enhancers Strong transcription Weak transcription Flanking Active TSS Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 78 gene(s) | inside rSNPs | diseases |
5 | nsv543340 | chr17:37333956-37795617 | Flanking Active TSS Strong transcription Enhancers Active TSS Weak transcription Genic enhancers Bivalent Enhancer ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 78 gene(s) | inside rSNPs | diseases |
6 | nsv908204 | chr17:37349655-37682657 | Genic enhancers Weak transcription Strong transcription Enhancers Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' Active TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 57 gene(s) | inside rSNPs | diseases |
7 | nsv1057057 | chr17:37395082-37627025 | Strong transcription Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 27 gene(s) | inside rSNPs | diseases |
8 | nsv1061951 | chr17:37442228-37770903 | Bivalent Enhancer Strong transcription Weak transcription Active TSS ZNF genes & repeats Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 44 gene(s) | inside rSNPs | diseases |
9 | nsv543341 | chr17:37442228-37770903 | Enhancers Weak transcription Flanking Active TSS Strong transcription Genic enhancers Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 44 gene(s) | inside rSNPs | diseases |
10 | esv1825702 | chr17:37487168-37876767 | Genic enhancers Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 53 gene(s) | inside rSNPs | diseases |
11 | nsv532712 | chr17:37521822-37768345 | Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer Genic enhancers Strong transcription Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 43 gene(s) | inside rSNPs | diseases |
12 | nsv1063848 | chr17:37575622-37707592 | Strong transcription Weak transcription Flanking Active TSS Active TSS Genic enhancers Enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 32 gene(s) | inside rSNPs | diseases |
13 | nsv827984 | chr17:37608583-37609302 | Enhancers Flanking Active TSS Active TSS Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | inside rSNPs | diseases |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:37608200-37611000 | Enhancers | Fetal Intestine Large | intestine |
2 | chr17:37608400-37609000 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |
3 | chr17:37608400-37612000 | Enhancers | Liver | Liver |
4 | chr17:37608400-37616800 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
5 | chr17:37608400-37617200 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
6 | chr17:37608600-37609000 | Weak transcription | Fetal Intestine Small | intestine |
7 | chr17:37608600-37609000 | Enhancers | Dnd41 | blood |
8 | chr17:37608600-37609000 | Enhancers | HepG2 | liver |
9 | chr17:37608600-37609800 | Weak transcription | A549 | lung |
10 | chr17:37608600-37614000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
11 | chr17:37608600-37616800 | Weak transcription | Hela-S3 | cervix |
12 | chr17:37608600-37617200 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
13 | chr17:37608800-37610200 | Weak transcription | K562 | blood |
14 | chr17:37608800-37616800 | Weak transcription | Right Ventricle | heart |